Injectable, rapid gelling and highly flexible hydrogel composites as growth factor and cell carriers.

A family of injectable, rapid gelling and highly flexible hydrogel composites capable of releasing insulin-like growth factor (IGF-1) and delivering mesenchymal stromal cell (MSC) were developed. Hydrogel composites were fabricated from Type I collagen, chondroitin sulfate (CS) and a thermosensitive and degradable hydrogel copolymer based on N-isopropylacrylamide, acrylic acid, N-acryloxysuccinimide and a macromer poly(trimethylene carbonate)-hydroxyethyl methacrylate. The hydrogel copolymer was gellable at body temperature before degradation and soluble at body temperature after degradation. Hydrogel composites exhibited LCSTs around room temperature. They could easily be injected through a 26-gauge needle at 4 degrees C, and were capable of gelling within 6s at 37 degrees C to form highly flexible gels with moduli matching those of the rat and human myocardium. The hydrogel composites showed good oxygen permeability; the oxygen pressure within the hydrogel composites was similar to that in the air. The effects of collagen and CS contents on LCST, gelation time, injectability, mechanical properties and degradation properties were investigated. IGF-1 was loaded into the hydrogel composites for enhanced cell survival/growth. The released IGF-1 remained bioactive during a 2-week release period. Small fraction of CS in the hydrogel composites significantly decreased IGF-1 release rate. The release kinetics appeared to be controlled mainly by hydrogel composite water content, degradation and interaction with IGF-1. Human MSC adhesion on the hydrogel composites was comparable to that on the tissue culture plate. MSCs were encapsulated in the hydrogel composites and were found to grow inside during a 7-day culture period. IGF-1 loading significantly accelerated MSC growth. RT-PCR analysis demonstrated that MSCs maintained their multipotent differentiation potential in hydrogel composites with and without IGF-1. These injectable and rapid gelling hydrogel composites demonstrated attractive properties for serving as growth factor and cell carriers for cardiovascular tissue engineering applications.

[1]  Randall J. Lee,et al.  The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. , 2009, Biomaterials.

[2]  R. Tuan,et al.  Identification and Functional Analysis of Candidate Genes Regulating Mesenchymal Stem Cell Self‐Renewal and Multipotency , 2006, Stem cells.

[3]  M. Radisic,et al.  Photocrosslinkable hydrogel for myocyte cell culture and injection. , 2007, Journal of biomedical materials research. Part B, Applied biomaterials.

[4]  A. Maruyama,et al.  Thermosensitive transparent semi-interpenetrating polymer networks for wound dressing and cell adhesion control. , 2008, Biomacromolecules.

[5]  S. Carbonetto,et al.  Nerve fiber growth on defined hydrogel substrates. , 1982, Science.

[6]  M. Tanihara,et al.  Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate. , 2001, Journal of biomedical materials research.

[7]  W. Hennink,et al.  In situ gelling hydrogels for pharmaceutical and biomedical applications. , 2008, International journal of pharmaceutics.

[8]  Sebastian Rammensee,et al.  Negative normal stress in semiflexible biopolymer gels. , 2007, Nature materials.

[9]  W. Baumgartner,et al.  Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. , 2002, The Annals of thoracic surgery.

[10]  E. Suuronen,et al.  Cellular and nerve regeneration within a biosynthetic extracellular matrix for corneal transplantation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Leroux,et al.  In situ-forming hydrogels--review of temperature-sensitive systems. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[12]  R. Kloner,et al.  Cellular cardiomyoplasty--cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? , 2003, Cardiovascular research.

[13]  John A. Pedersen,et al.  Mechanobiology in the Third Dimension , 2005, Annals of Biomedical Engineering.

[14]  Antonios G Mikos,et al.  Thermoresponsive hydrogels in biomedical applications. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[15]  Seung‐Woo Cho,et al.  Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. , 2005, Biomaterials.

[16]  A. Mikos,et al.  In vitro generation of an osteochondral construct using injectable hydrogel composites encapsulating rabbit marrow mesenchymal stem cells. , 2009, Biomaterials.

[17]  J. Vacanti,et al.  Percutaneous transvenous cellular cardiomyoplasty , 2002 .

[18]  B. Baroli,et al.  Hydrogels for tissue engineering and delivery of tissue-inducing substances. , 2007, Journal of pharmaceutical sciences.

[19]  Wim E. Hennink,et al.  Novel crosslinking methods to design hydrogels , 2002 .

[20]  Samuel T Wall,et al.  Theoretical Impact of the Injection of Material Into the Myocardium: A Finite Element Model Simulation , 2006, Circulation.

[21]  C. van Nostrum,et al.  The effect of the processing and formulation parameters on the size of nanoparticles based on block copolymers of poly(ethylene glycol) and poly(N-isopropylacrylamide) with and without hydrolytically sensitive groups. , 2004, Biomaterials.

[22]  Richard T. Lee,et al.  Injectable Self-Assembling Peptide Nanofibers Create Intramyocardial Microenvironments for Endothelial Cells , 2005, Circulation.

[23]  F. Giorgino,et al.  The IGF-I signaling pathway. , 2007, Current pharmaceutical design.

[24]  Mitsuo Umezu,et al.  Fabrication of Pulsatile Cardiac Tissue Grafts Using a Novel 3-Dimensional Cell Sheet Manipulation Technique and Temperature-Responsive Cell Culture Surfaces , 2002, Circulation research.

[25]  S. Sen,et al.  Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.

[26]  Ping H Wang,et al.  IGF-I is a matter of heart. , 2005, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[27]  A A Poot,et al.  In vivo behavior of poly(1,3-trimethylene carbonate) and copolymers of 1,3-trimethylene carbonate with D,L-lactide or epsilon-caprolactone: Degradation and tissue response. , 2003, Journal of biomedical materials research. Part A.

[28]  N. Ravi,et al.  Refilling of ocular lens capsule with copolymeric hydrogel containing reversible disulfide. , 2005, Biomacromolecules.

[29]  Xian‐Zheng Zhang,et al.  Novel thermosensitive hydrogel injection inhibits post‐infarct ventricle remodelling , 2009, European journal of heart failure.

[30]  H. Blau,et al.  Self-renewal and expansion of single transplanted muscle stem cells , 2008, Nature.

[31]  Jennifer L West,et al.  Enhancing mechanical properties of tissue-engineered constructs via lysyl oxidase crosslinking activity. , 2003, Journal of biomedical materials research. Part A.

[32]  M. Aoki,et al.  In vivo transfer efficiency of antisense oligonucleotides into the myocardium using HVJ-liposome method. , 1997, Biochemical and biophysical research communications.

[33]  Ashutosh Chilkoti,et al.  Targeted drug delivery by thermally responsive polymers. , 2002, Advanced drug delivery reviews.

[34]  C. Kelche,et al.  Synthesis and rheological properties of hydrogels based on amphiphilic alginate-amide derivatives. , 2009, Carbohydrate research.

[35]  H. Lee,et al.  Chitosan Gel as an In Situ–Forming Scaffold for Rat Bone Marrow Mesenchymal Stem Cells In Vivo , 2008 .

[36]  G. Bidwell,et al.  Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin-like polypeptide , 2008 .

[37]  A. Yodh,et al.  Local and global deformations in a strain-stiffening fibrin gel , 2007 .

[38]  Paul D. Kessler,et al.  Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.

[39]  Lin Yu,et al.  Injectable hydrogels as unique biomedical materials. , 2008, Chemical Society reviews.

[40]  Antonios G Mikos,et al.  Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[41]  Jennifer L West,et al.  Photocrosslinkable polyvinyl alcohol hydrogels that can be modified with cell adhesion peptides for use in tissue engineering. , 2002, Biomaterials.

[42]  J. Guan,et al.  Biodegradable elastomeric scaffolds with basic fibroblast growth factor release. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[43]  P. Kuppusamy,et al.  Simultaneous measurement of oxygenation in intracellular and extracellular compartments of lung microvascular endothelial cells. , 2004, Antioxidants & redox signaling.

[44]  K. Anseth,et al.  Synthetic hydrogel niches that promote hMSC viability. , 2005, Matrix biology : journal of the International Society for Matrix Biology.

[45]  T. Okano,et al.  Temperature-responsive polymeric carriers incorporating hydrophobic monomers for effective transfection in small doses. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[46]  Jyh-Ping Chen,et al.  Preparation and evaluation of thermo-reversible copolymer hydrogels containing chitosan and hyaluronic acid as injectable cell carriers , 2009 .

[47]  C. Lim,et al.  Collagen-based fibrous scaffold for spatial organization of encapsulated and seeded human mesenchymal stem cells. , 2009, Biomaterials.

[48]  K. Healy,et al.  Synthesis and characterization of injectable poly(N-isopropylacrylamide-co-acrylic acid) hydrogels with proteolytically degradable cross-links. , 2003, Biomacromolecules.

[49]  Randall J Lee,et al.  Biomaterials for the treatment of myocardial infarction. , 2006, Journal of the American College of Cardiology.

[50]  Ick Chan Kwon,et al.  Effects of the controlled-released TGF-beta 1 from chitosan microspheres on chondrocytes cultured in a collagen/chitosan/glycosaminoglycan scaffold. , 2004, Biomaterials.

[51]  Jay L Zweier,et al.  Novel particulate spin probe for targeted determination of oxygen in cells and tissues. , 2003, Free radical biology & medicine.

[52]  Giselle Chamberlain,et al.  Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing , 2007, Stem cells.

[53]  B. Lee,et al.  In situ-gelling, erodible N-isopropylacrylamide copolymers. , 2005, Macromolecular bioscience.

[54]  Ge Zhang,et al.  Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix. , 2008, Tissue engineering. Part A.

[55]  J. San Román,et al.  Starch-based biodegradable hydrogels with potential biomedical applications as drug delivery systems. , 2002, Biomaterials.

[56]  J. Zweier,et al.  Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function. , 2007, American journal of physiology. Heart and circulatory physiology.

[57]  S. Bryant,et al.  Cell encapsulation in biodegradable hydrogels for tissue engineering applications. , 2008, Tissue engineering. Part B, Reviews.

[58]  Y. Bae,et al.  Thermosensitive sol-gel reversible hydrogels. , 2002, Advanced drug delivery reviews.

[59]  Qizhi Chen,et al.  Biomaterials in cardiac tissue engineering: Ten years of research survey , 2008 .

[60]  J. Leor,et al.  The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. , 2009, Biomaterials.

[61]  G. Shambaugh,et al.  A new method for the detection of viable cells in tissue sections using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT): an application in the assessment of tissue damage by surgical instruments , 1993, Virchows Archiv. B, Cell pathology including molecular pathology.

[62]  A. Sun,et al.  Time course of myocardial stromal cell–derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction , 2005, Basic Research in Cardiology.

[63]  Ching-Pin Chang,et al.  Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. , 2004, The Journal of thoracic and cardiovascular surgery.

[64]  Kytai Truong Nguyen,et al.  Photopolymerizable hydrogels for tissue engineering applications. , 2002, Biomaterials.

[65]  Yen-Chih Huang,et al.  Modulating the Functional Performance of Bioengineered Heart Muscle Using Growth Factor Stimulation , 2008, Annals of Biomedical Engineering.

[66]  Sung Wan Kim,et al.  Biodegradable block copolymers as injectable drug-delivery systems , 1997, Nature.

[67]  D G Stein,et al.  Biocompatibility of methylcellulose-based constructs designed for intracerebral gelation following experimental traumatic brain injury. , 2001, Biomaterials.

[68]  Jun Du,et al.  Involvement of MEKK1/ERK/P21Waf1/Cip1 signal transduction pathway in inhibition of IGF‐I‐mediated cell growth response by methylglyoxal , 2003, Journal of cellular biochemistry.

[69]  Freddie H. Fu,et al.  Improved Muscle Healing after Contusion Injury by the Inhibitory Effect of Suramin on Myostatin, a Negative Regulator of Muscle Growth , 2008, The American journal of sports medicine.

[70]  J. Veerkamp,et al.  Attachment of glycosaminoglycans to collagenous matrices modulates the tissue response in rats. , 2000, Biomaterials.

[71]  Zu-wei Ma,et al.  Protein-reactive, thermoresponsive copolymers with high flexibility and biodegradability. , 2008, Biomacromolecules.